µTASWako™ AFP-L3 Test

µTASWako™ AFP-L3 Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).

Product information

µTASWako™ AFP-L3 Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).

AFP-L3 is an isoform of the glycoprotein alpha-fetoprotein (AFP). It has an additional α 1-6 fucose residue attached at the reducing end of N-acetylglucosamine. Using affinity electrophoresis with the lectin Lens culinaris agglutinin (LCA), AFP can be fractionated into the three variants L1, L2 and L3. AFP-L1 with the lowest affinity for LCA is the most prevalent fraction in patients with non-malignant liver diseases like chronic hepatitis or liver cirrhosis.

µTASWako™ AFP-L3 Test measures the ratio of AFP-L3 to total AFP as percentage and allows an early diagnosis of HCC. This test is run on the µTASWako™ i30 device.

All test components are CE-certified.

Click here for more information for Health Care Providers.

Key Features

CE-marked in vitro diagnostic test
Superior specificity for HCC

Storage

Store at 2-10° C.

Safety Information

Health Hazard

Serious Health Hazard

Corrosive

Literature

For more information and the latest publications please visit Videos & Publications.

Ordering information

Name	Volume	Article number
μTASWako AFP-L3	1 cartridge (100 tests)	999-60601
μTASWako AFP-L3 Calibrator	1 set	997-60901
μTASWako AFP-L3 Control L	4 x 2 ml	997-61001
μTASWako AFP-L3 Control H	4 x 2 ml	993-61101
μTASWako AFP-L3 Dilution Buffer	3 x 10 ml	997-61501
μTASWako Wash Solution	4 x 60 ml	991-60801
μTASWako Sample Cup S	1000 units	452-00501
μTASWako Printer Paper	1 unit	991-60811
μTASWako Chip Cassette	5 x 20 units	993-61601
μTASWakoTM i30 Analyzer	1 unit	991-60301